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Introduction
Despite the use of smaller caliber angiographic
and interventional catheters and the advent of new
closure techniques, adverse events related to the
arterial access site remain the most common non-
coronary complication following diagnostic and in-
terventional cardiac catheterization. While typical-
ly not life threatening, arterial access site compli-
cations can be associated with significant patient
discomfort, lengthened hospitalization, and incre-
ased economic costs.
Incidence and risk factors
Among potential vascular complications rela-
ted to femoral artery puncture, arterial pseudoaneu-
rysm is the most frequent with a reported inciden-
ce ranging from < 0.5% to 6.3% [1]. Other access
related events include femoral arteriovenous fistu-
la formation, noted in 0.2 to 2.1% of procedures, and
the less common but potentially more dangerous
occurrence of retroperitoneal hemorrhage following
0.1 to 0.5% of catheterization procedures [1]. An
arterial pseudoaneurysm occurs as the result of in-
complete closure of the femoral vessel following
removal of the vascular sheath. An extravascular
hematoma develops adjacent to the incompletely
sealed arteriotomy site, and persistent hemorrha-
ge from the artery with continued expansion of the
hematoma can occur.
Previous studies have identified a variety of
patient and operator related factors that may pre-
dispose to pseudoaneurysm formation. Among pa-
tient-specific features, female gender, the presen-
ce of diabetes mellitus (both of which may be asso-
ciated with smaller femoral artery size) and obesity
(which can render direct manual pressure of the
artery more difficult) have been identified as pre-
dictors of pseudoaneurysm development. From
a technical standpoint, failure to puncture and in-
sert the arterial sheath in the common femoral ar-
tery proper, above its bifurcation into the superfi-
cial femoral artery and profunda femoris, has been
shown to increase the risk of pseudoaneurysm for-
mation. The presence or absence of a relationship
between arterial sheath size and pseudoaneurysm
development has been inconsistent among studies [2].
Interestingly, in a recent analysis at one institution,
pseudoaneurysms were noted to occur more frequ-
ently on days that a greater number of cases were
performed, presumably because less time and
attention were given to groin compression on bu-
sier days [3].
How to remove an arterial sheath?
Despite the fact that well over one million an-
giographic procedures are performed worldwide on
an annual basis, no standardized approach for achie-
ving access site hemostasis exists among hospitals,
or at times even amongst physicians within the
same institution. Variations exist with respect to
virtually all aspects of the process, including me-
thod of groin compression (digital pressure versus
use of a C-clamp or elastic band-type device), the
amount of time that compression is maintained, the
level of anticoagulation at which the sheath
is removed (usually measured by the activated
clotting time following coronary interventional
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procedures), and the amount of bed rest required
after hemostasis is achieved before.
In addition, over the past decade, a variety of
“vascular closure” devices have been introduced
that allow immediate removal of the arterial she-
ath with rapid hemostasis at the termination of
a diagnostic or interventional procedure. As with
the other parameters mentioned above, there is
substantial variability among physicians in the use
of these devices. With closure devices, hemostasis
is typically achieved via the percutaneous delivery
of a suture, clip, or procoagulant material to the ar-
teriotomy site, and the devices can be used even if
the patient remains fully anticoagulated. While
expensive, these devices have demonstrated the
ability to increase patient comfort by reducing be-
drest times, and despite their up-front financial cost
may reduce overall hospital expenses by permitting
earlier ambulation and hospital discharge.
The major potential drawback of vascular clo-
sure devices relates to the retained foreign mate-
rial (suture or other material, depending on device
type) left behind at the puncture site, which may
render early re-puncture of the same artery proble-
matic, and can predispose to rare but potentially
devastating infectious complications [4]. Despite
the practical advantages of these devices, they do
not appear to be associated with a reduction in the
incidence of arterial complications following cathe-
terization. One meta-analysis examined 30 trials
that compared various closure devices to manual
compression. No significant differences were noted
in the incidence of major or minor access related
complications based on closure technique; Howe-
ver when the analysis was restricted to include only
studies that employed the most rigorous design and
analysis techniques, the use of vascular closure
devices was associated with a significant excess risk
of femoral pseudoaneurysm formation (odds ratio 5.4,
95% confidence interval 1.21–24.5) [5]. A second
meta-analysis that included trials involving a total
of 37,066 patients showed a slight increase in ac-
cess-site related complications among patients tre-
ated with a closure device rather than manual com-
pression (odds ratio 1.01, 95% confidence interval
1.01–1.79) [6].
Treatment options
When a femoral artery pseudoaneurysm does
occur, several treatment options exist. The least
invasive approach consists of reapplication of exter-
nal pressure over the incompletely sealed arterio-
tomy site, which is often continued for several ho-
urs using an elastic-type compression device. Be-
cause a large painful hematoma invariably lies be-
tween the skin and the leaking femoral artery, pro-
longed external compression can be quite uncom-
fortable for the patient. Furthermore, the presence
of the hematoma overlying the arteriotomy site may
diffuse the external pressure away from the area of
leakage, resulting in failure to achieve hemostasis.
A second technique, designed to overcome these
issues, involves the use of duplex ultrasound to
precisely localize the site of arterial leakage. The
ultrasound probe itself can then be used to apply
focused pressure over the specific site of the arte-
rial leak. This focused technique typically requires
pressure to be applied for a much shorter duration,
which can improve patient comfort, and is typically
associated with successful closure in 60–90% of
cases [7, 8]. When these approaches fail, ultraso-
und can be used to guide the percutaneous injec-
tion of thrombin directly into the pseudoaneurysm
cavity, a technique that is associated with a high
degree of safety and efficacy [9, 10].
Current study
The study of Kaźmierski and colleagues that
appears in this issue of “Folia Cardiologica” provi-
des a detailed overview of the incidence and mana-
gement femoral artery pseudoaneurysm in a large
population of patients undergoing diagnostic and
interventional cardiac catheterization procedures at
a single center, and serves to expand upon previo-
us findings. Among the 8,279 patients analyzed, the
overall incidence of pseudoaneurysm was quite low,
at 0.7%. As is standard in clinical practice, ultraso-
nography to screen for pseudoaneurysm was only
performed when a symptom (typically groin pain or
hematoma) or sign (femoral bruit) suggestive of an
arterial complication was present. Interestingly, no
other arterial access complications aside from pseu-
doaneurysm (such as arteriovenous fistula and re-
troperitoneal bleeding) were noted in this series of
patients. Unlike most previous reports, no associa-
tions between various clinical features and pseudo-
aneurysm formation were noted, including female
gender, hypertension, diabetes mellitus or periphe-
ral arteriosclerosis. There was likewise no relation-
ship between arterial sheath size and pseudoaneu-
rysm development. The authors do not comment
on whether or not body weight served as a predic-
tor of pseudoaneurysm. One important omission in
this report is the lack of a description by the authors
of the protocol by which arterial sheaths are remo-
ved at their institution, including details such as the
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frequency of vascular closure device use, the length
of time manual compression is typically applied fol-
lowing sheath removal at their institution, the acti-
vated clotting time threshold used to permit she-
ath removal, and the typical length of bedrest after
hemostasis is achieved. It is also not mentioned
whether other procedurally related factors were
associated with groin complications, including pro-
cedural duration, procedural activated clotting time,
and procedural success.
The authors provide a description of the algo-
rithm used at their center for the treatment of pseu-
doaneurysm, which follows the logical progression
from repeat compression for 8 hours, followed by
ultrasound-guided compression, and finally to
thrombin injection if the prior techniques fail. This
sequential approach ultimately provided obliteration
of the pseudoaneurysm in all patients studied. Re-
markably, only one individual out of the over 8,000
patients studied required an open surgical vascular
repair. Given the safety and efficacy of both ultra-
sound-directed compression and collagen injection,
one might question whether, for the sake of expe-
diency and patient comfort, it would be reasonable
to forego the initial attempt at prolonged repeat
compression and proceed directly to one of these
other less painful and highly effective techniques.
Prevention: should we abandon the groin?
One increasingly popular approach aimed at
reducing vascular access complications and provi-
ding improved patient comfort is the use of the ra-
dial artery for performing diagnostic and therapeu-
tic catheterization. One meta-analysis of several
studies comparing radial to femoral artery access
for diagnostic or interventional coronary procedu-
res documented a 5-fold reduction in entry site com-
plications among individuals who received radial
artery access [11]. The incidence of major adverse
cardiac events was not affected by route of access,
however radial artery access was associated with
a significantly increased rate of “procedure failure”,
necessitating crossover to the femoral approach.
Other potential drawbacks of the radial appro-
ach include its steep learning curve and the greater
technical demands this approach places on the ope-
rator. Even for experts, compared to the femoral
approach, radial artery access is associated with gre-
ater procedural times and radiation exposure [12].
Nevertheless, with improvements in operator expe-
rience and equipment, selective use of the radial
artery can serve as a useful alternative to femoral
access, especially for patients in whom obtaining
femoral artery access may be difficult or potential-
ly associated with a heightened risk of complica-
tions, such as individuals with obesity or periphe-
ral arterial disease. Even so, the very low rate of
access site complications and exceptionally rare
need for open vascular repair following femoral ar-
tery catheterization observed by Kaźmierski and
colleagues provides reassurance that the femoral
approach remains a safe means of achieving vascu-
lar access that will certainly and deservedly conti-
nue to endure.
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